Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogens and atherosclerosis.

J-F Arnal1, P Gourdy, R Elhage

  • 1INSERM U589, Institut L Bugnard, 1 avenue Jean Poulhes, 31403 Toulouse, France.

European Journal of Endocrinology
|February 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut commensal Bacteroides faecichinchillae, a potential novel candidate of next-generation probiotics targeting type 2 diabetes.

Beneficial microbes·2026
Same author

Sperm functional and morphometric differences between Iberian and European ecotypes of capercaillie (Tetrao urogallus L.).

Animal reproduction science·2025
Same author

Catalase, superoxide dismutase and butylated hydroxytoluene benefit mid-term storage of red-legged partridge sperm (<i>Alectoris rufa</i>).

British poultry science·2024
Same author

Revealing uncertainty in the status of biodiversity change.

Nature·2024
Same author

15-Lipoxygenase promotes resolution of inflammation in lymphedema by controlling T<sub>reg</sub> cell function through IFN-β.

Nature communications·2024
Same author

Review: Sperm cryopreservation in wild small ruminants: morphometric, endocrine and molecular basis of cryoresistance.

Animal : an international journal of animal bioscience·2023
Same journal

Long-term Cancer Risk in Acromegaly: A Population-Based Cohort Study with 44 Years of Follow-up.

European journal of endocrinology·2026
Same journal

Psychosocial retrospective follow-up of young adults with congenital adrenal hyperplasia.

European journal of endocrinology·2026
Same journal

Correction to: Steroidogenic factor-1 regulates a core set of target genes to promote malignancy in adrenocortical carcinoma.

European journal of endocrinology·2026
Same journal

Improving post-thyroidectomy care using a PTH and calcium-based algorithm.

European journal of endocrinology·2026
Same journal

Sampling variability and concordance between sequential and simultaneous adrenal venous sampling in primary aldosteronism subtype diagnosis.

European journal of endocrinology·2026
Same journal

Independent Clonal Evolution in Primary Pigmented Nodular Adrenocortical Disease: A Single-Patient Multi-Omics Study.

European journal of endocrinology·2026
See all related articles

Estradiol (E2) may paradoxically promote atherosclerosis by inducing an inflammatory response, despite some beneficial effects on nitric oxide (NO) bioavailability. This finding helps explain cardiovascular risks associated with hormone replacement therapy (HRT).

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Immunology

Background:

  • Epidemiological and experimental studies suggested estradiol (E2) prevents atherosclerosis.
  • However, hormone replacement therapy (HRT) studies in women showed conflicting results.
  • Mouse models were used to investigate the discrepancy in E2's effect on atherosclerosis.

Purpose of the Study:

  • To elucidate the mechanisms behind estradiol's (E2) role in atherosclerosis development.
  • To understand why HRT did not confirm E2's atheroprotective effects.
  • To identify potential reasons for increased cardiovascular events in women using HRT.

Main Methods:

  • Utilized mouse models of atherosclerosis.
  • Assessed changes in lipid metabolism and serum cholesterol.

Related Experiment Videos

  • Analyzed inflammatory-immune responses, including T helper cell (Th1) profiles and interferon-gamma production.
  • Investigated nitric oxide (NO) bioavailability at the endothelial level.

    • Main Results:

    • Estradiol (E2) showed negligible influence on lipid metabolism, despite decreasing serum cholesterol.
    • E2 induced a pro-inflammatory immune response, favoring a T helper cell (Th1) profile and increasing interferon-gamma.
    • This inflammatory response could destabilize atheromatous plaques and increase cardiovascular events.
    • E2 increased endothelial nitric oxide (NO) bioavailability, but this did not affect fatty streak development.

    Conclusions:

    • Estradiol's (E2) atheroprotective effect may be counteracted by its induction of an inflammatory-immune response.
    • The Th1-biased immune response and increased interferon-gamma may explain cardiovascular risks associated with HRT.
    • Endothelial mechanisms for atheroprotection by E2 require further molecular characterization.
    • Findings support developing strategies to mitigate detrimental effects while preserving beneficial ones of E2.